Song, M. M., Tolcher, A. W., Gutierrez, M. E., Zsiros, E., Fu, S., Liu, J. F., Morgensztern, D., Kordahi, S., Nietubicz, C., Barbu, E. A., Morawski, A., Kahan, S., Kothari, P., Flies, D., Selvam, S. P., Slocum, S., Ruiz-Soto, R., Langermann, S., Guha, U., Mahadevan, D. (2025). A phase 1 dose escalation and dose expansion study for LNCB74, a B7-H4 targeted antibody drug conjugate, as monotherapy in participants with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps3167